CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
27 hedge funds and large institutions have $93M invested in Crescent Biopharma, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 10 closing their positions.
Holders
27
Holders Change
-5
Holders Change %
-15.63%
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
4
Reduced
10
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $1K | 172 | +172 | New |
|
27
Citigroup
New York
| $1K | 186 | +186 | New |
|
|
DCM
28
Driehaus Capital Management
Chicago,
Illinois
| – | – | -60,465 | Closed |
|
|
PP
29
Paloma Partners
Greenwich,
Connecticut
| – | – | -34,514 | Closed |
|
|
COPPSERS
30
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
| – | – | -23,026 | Closed |
|
|
LP
31
LMR Partners
London,
United Kingdom
| – | – | -19,652 | Closed |
|
32
Millennium Management
New York
| – | – | -13,600 | Closed |
|
|
SFM
33
Soros Fund Management
New York
| – | – | -10,300 | Closed |
|
|
CS
34
Credit Suisse
Zurich,
Switzerland
| – | – | -10,126 | Closed |
|
35
Barclays
London,
United Kingdom
| – | – | -8,299 | Closed |
|
36
Morgan Stanley
New York
| – | – | -6,620 | Closed |
|
37
Bank of Montreal
Toronto,
Ontario, Canada
| – | – | -210 | Closed |
|